Jane Street’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,300
Closed -$202K 11263
2025
Q3
$202K Buy
+4,300
New +$223K ﹤0.01% 9669
2025
Q2
Sell
-10,000
Closed -$604K 9765
2025
Q1
$604K Buy
+10,000
New +$645K ﹤0.01% 6516
2024
Q4
Sell
-3,400
Closed -$245K 9522
2024
Q3
$245K Sell
3,400
-10,800
-76% -$762K ﹤0.01% 8357
2024
Q2
$984K Buy
+14,200
New +$1.04M ﹤0.01% 5805
2024
Q1
Sell
-5,300
Closed -$580K 9284
2023
Q4
$580K Buy
+5,300
New +$548K ﹤0.01% 6504
2023
Q1
Sell
-3,100
Closed -$275K 9131
2022
Q4
$275K Buy
+3,100
New +$257K ﹤0.01% 7166

Other funds holding CNMD

Jane Street's CNMD Position: Q1 2026 in Review

Jane Street reduced its CONMED (CNMD) stake by 65% in Q1 2026, selling an estimated $7.32M and leaving 96,923 shares worth $3.43M. The position accounts for ﹤0.01% of the portfolio, ranked #4114.

Jane Street first reported a position in CNMD in Q1 2020 and has held it in 24 quarters since. The position peaked at $11.2M in Q4 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Jane Street held 96,923 shares of CONMED worth $3.43M as of Q1 2026.
  • Jane Street sold 179,935 CONMED shares in Q1 2026, an estimated $7.32M.
  • CONMED made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4114 holding.
  • Jane Street first reported a position in CONMED in Q1 2020 and has held it in 24 quarters since.
  • Jane Street's CONMED position peaked at $11.2M in Q4 2025.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.